Skip to content
November 10, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
The Future of Breast Reconstruction: Autologous Fat Transfer Offers a Natural Alternative Post-Mastectomy the-future-of-breast-reconstruction-autologous-fat-transfer-offers-a-natural-alternative-post-mastectomy
  • Breast Cancer Surgery and Reconstruction

The Future of Breast Reconstruction: Autologous Fat Transfer Offers a Natural Alternative Post-Mastectomy

Jia Lissa October 10, 2026
For decades, the standard path for breast reconstruction following a mastectomy has been binary: either the insertion...
Read More Read more about The Future of Breast Reconstruction: Autologous Fat Transfer Offers a Natural Alternative Post-Mastectomy
Biotech Industry Pulse: Market Volatility, Regulatory Shifts, and Strategic Capital Moves biotech-industry-pulse-market-volatility-regulatory-shifts-and-strategic-capital-moves
  • Chemotherapy and Targeted Therapy

Biotech Industry Pulse: Market Volatility, Regulatory Shifts, and Strategic Capital Moves

Nila Kartika Wati October 10, 2026
The biotechnology sector continues to navigate a complex landscape of clinical setbacks, regulatory breakthroughs, and tactical financial...
Read More Read more about Biotech Industry Pulse: Market Volatility, Regulatory Shifts, and Strategic Capital Moves
The Digital Renaissance of Pathology: Mining Archives to Redefine Preclinical Research the-digital-renaissance-of-pathology-mining-archives-to-redefine-preclinical-research-6
  • Chemotherapy and Targeted Therapy

The Digital Renaissance of Pathology: Mining Archives to Redefine Preclinical Research

Basiran October 10, 2026
In the landscape of modern drug discovery, a profound paradigm shift is underway. For decades, the pathology...
Read More Read more about The Digital Renaissance of Pathology: Mining Archives to Redefine Preclinical Research
Turning Darkness Into Hope: The Global Movement to Illuminate Metastatic Breast Cancer Awareness turning-darkness-into-hope-the-global-movement-to-illuminate-metastatic-breast-cancer-awareness
  • Metastatic Breast Cancer Research

Turning Darkness Into Hope: The Global Movement to Illuminate Metastatic Breast Cancer Awareness

Jia Lissa October 10, 2026
NEW YORK, NY — October 8, 2026 — As Breast Cancer Awareness Month unfolds across the globe,...
Read More Read more about Turning Darkness Into Hope: The Global Movement to Illuminate Metastatic Breast Cancer Awareness
A Beacon of Resilience: WHO Director-General Strengthens Global Health Ties During Landmark Visit to Jordan a-beacon-of-resilience-who-director-general-strengthens-global-health-ties-during-landmark-visit-to-jordan-1
  • Global Breast Cancer Awareness

A Beacon of Resilience: WHO Director-General Strengthens Global Health Ties During Landmark Visit to Jordan

Azzam Bilal Chamdy October 10, 2026
AMMAN — The Hashemite Kingdom of Jordan has once again cemented its status as a vital anchor...
Read More Read more about A Beacon of Resilience: WHO Director-General Strengthens Global Health Ties During Landmark Visit to Jordan
Navigating Life After Breast Cancer: A Comprehensive Guide to Recovery, Nutrition, and Emotional Well-being navigating-life-after-breast-cancer-a-comprehensive-guide-to-recovery-nutrition-and-emotional-well-being
  • Global Breast Cancer Awareness

Navigating Life After Breast Cancer: A Comprehensive Guide to Recovery, Nutrition, and Emotional Well-being

Laily UPN October 10, 2026
For many patients, the end of active breast cancer treatment—chemotherapy, radiation, or surgery—is not the finish line,...
Read More Read more about Navigating Life After Breast Cancer: A Comprehensive Guide to Recovery, Nutrition, and Emotional Well-being
Breakthrough at University of Oklahoma Uncovers Cancer’s Neural Deception, Offering New Hope for Aggressive Breast Cancer breakthrough-at-university-of-oklahoma-uncovers-cancers-neural-deception-offering-new-hope-for-aggressive-breast-cancer
  • Medical Research and Clinical Trials

Breakthrough at University of Oklahoma Uncovers Cancer’s Neural Deception, Offering New Hope for Aggressive Breast Cancer

Rifan Muazin October 10, 2026
Oklahoma City, OK – In a significant stride against one of the most formidable adversaries in oncology,...
Read More Read more about Breakthrough at University of Oklahoma Uncovers Cancer’s Neural Deception, Offering New Hope for Aggressive Breast Cancer
Navigating the Nexus: GLP-1 Medications and Breast Cancer – Unpacking the Latest Insights navigating-the-nexus-glp-1-medications-and-breast-cancer-unpacking-the-latest-insights
  • Patient Advocacy and Support

Navigating the Nexus: GLP-1 Medications and Breast Cancer – Unpacking the Latest Insights

Iffa Jayyana October 10, 2026
By Douglas Feil, NBCF Chief Program Officer The landscape of medical treatment is constantly evolving, and recent...
Read More Read more about Navigating the Nexus: GLP-1 Medications and Breast Cancer – Unpacking the Latest Insights
Shining a Global Light on the Stage 4 Reality: The 2026 #LightUpMBC Campaign shining-a-global-light-on-the-stage-4-reality-the-2026-lightupmbc-campaign
  • Patient Advocacy and Support

Shining a Global Light on the Stage 4 Reality: The 2026 #LightUpMBC Campaign

Suro Senen October 10, 2026
NEW YORK, NY — As the world dons pink ribbons for Breast Cancer Awareness Month this October,...
Read More Read more about Shining a Global Light on the Stage 4 Reality: The 2026 #LightUpMBC Campaign
A New Standard in Metastatic Care: FDA Approves Tucatinib Combination as First-Line Maintenance for HER2-Positive Breast Cancer Set iv fluid intravenous drop saline drip hospital room,Medical Concept,treatment emergency and injection drug infusion care chemotherapy, concept.blue light background,selective focus stock photo
  • Patient Advocacy and Support

A New Standard in Metastatic Care: FDA Approves Tucatinib Combination as First-Line Maintenance for HER2-Positive Breast Cancer

Iffa Jayyana October 10, 2026
Introduction In a significant advancement for the oncology community and thousands of patients nationwide, the U.S. Food...
Read More Read more about A New Standard in Metastatic Care: FDA Approves Tucatinib Combination as First-Line Maintenance for HER2-Positive Breast Cancer

Posts pagination

Previous 1 … 154 155 156 157 158 159 160 … 877 Next

Recent Posts

  • A New Horizon in Breast Cancer Prevention: Targeting Obesity and Metabolism for High-Risk Women
  • Familial hypercholesterolemia linked to increased odds of preeclampsia
  • AI-Driven Breakthrough: Insilico Medicine’s ISM6331 Shows Promise in Mesothelioma Clinical Trials
  • From Curiosity to Clinical Impact: The Inspiring Journeys of the Genomics Training Academy Team
  • Wake Up and Flow: The Science and Practice of a 7-Minute Morning Yoga Reset

Recent Comments

No comments to show.

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

a-new-horizon-in-breast-cancer-prevention-targeting-obesity-and-metabolism-for-high-risk-women
  • Medical Research and Clinical Trials

A New Horizon in Breast Cancer Prevention: Targeting Obesity and Metabolism for High-Risk Women

Nana November 9, 2026
familial-hypercholesterolemia-linked-to-increased-odds-of-preeclampsia
  • Medical Research and Clinical Trials

Familial hypercholesterolemia linked to increased odds of preeclampsia

Neng Nana November 9, 2026
ai-driven-breakthrough-insilico-medicines-ism6331-shows-promise-in-mesothelioma-clinical-trials
  • Treatment Innovations

AI-Driven Breakthrough: Insilico Medicine’s ISM6331 Shows Promise in Mesothelioma Clinical Trials

Nila Kartika Wati November 9, 2026
from-curiosity-to-clinical-impact-the-inspiring-journeys-of-the-genomics-training-academy-team
  • Genomics and Precision Medicine

From Curiosity to Clinical Impact: The Inspiring Journeys of the Genomics Training Academy Team

Sagoh November 9, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.